Premium
Plasma biomarker identification in S ‐adenosylhomocysteine hydrolase deficiency
Author(s) -
Sedic Mirela,
Kraljevic Pavelic Sandra,
Cindric Mario,
Vissers Johannes P. C.,
Peronja Marija,
Josic Djuro,
Cuk Mario,
Fumic Ksenija,
Pavelic Krešimir,
Baric Ivo
Publication year - 2011
Publication title -
electrophoresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 158
eISSN - 1522-2683
pISSN - 0173-0835
DOI - 10.1002/elps.201000556
Subject(s) - biomarker , biochemistry , chemistry
S ‐Adenosylhomocysteine hydrolase (AHCY) deficiency is a rare congenital disorder in methionine metabolism clinically characterized by white matter atrophy, delayed myelination, slowly progressive myopathy, retarded psychomotor development and mildly active chronic hepatitis. In the present study, we utilized a comparative proteomics strategy based on 2‐DE/MALDI‐MS and LC/ESI‐MS to analyze plasma proteins from three AHCY‐deficient patients prior to and after receiving dietary treatment designed to alleviate disease symptoms. Obtained results revealed candidate biomarkers for the detection of myopathy specifically associated with AHCY deficiency, such as carbonic anhydrase 3, creatine kinase, and thrombospondin 4. Several proteins mediating T‐cell activation and function were identified as well, including attractin and diacylglycerol kinase α. Further validation and functional analysis of identified proteins with clinical value would ensure that these biomarkers make their way into routine diagnosis and management of AHCY deficiency.